2 ms·
And yet the "bad guy" generic manufacturer was able to raise the capital to do this (and presumably make a profit). What's the difference?
by twoodfin 11y ago
And yet the "bad guy" generic manufacturer was able to raise the capital to do this (and presumably make a profit). What's the difference?
- ScottBev 11y agoTuring only acquired the US marketing rights. Someone else is making the drug. So that doesn't change the FDA licensing, but they get to increase the price in the US. http://www.prnewswire.com/news-releases/turing-pharmaceuticals-ag-acquires-us-marketing-rights-to-daraprim-pyrimethamine-300125853.html http://www.prnewswire.com/news-releases/turing-pharmaceutica...